Postmenopause Study
Testosterone for low libido and bone health after menopause
This medical study aims to determine whether an approved testosterone therapy for women is effective in preventing bone loss and improving libido in postmenopausal women who are taking the standard dose of oestrogen.
Eligibility
- 18-54 years
- Postmenopausal OR had both ovaries removed before 54 years of age.
- Been on a stable dose of hormone replacement therapy (HRT) for at least 3 months.
Location
VIC and WA
Respiratory Studies
Help researchers investigate potential new treatments for respiratory conditions.
Eligibility
- Chronic cough
- COPD
- IPF
Location
WA